NCT00073398 2020-05-28Vaccine Treatment for Advanced Non-Small Cell Lung CancerLumos PharmaPhase 1/2 Completed54 enrolled
NCT00404924 2016-09-30ZD6474 (ZACTIMAâ„¢) Phase III Study in EGFR FailuresSanofiPhase 3 Completed1,140 enrolled 12 charts
NCT01362400 2014-05-19A Double-blind Study Evaluating IPI-504 and Docetaxel in Patients With Non-Small Cell Lung CancerInfinity Pharmaceuticals, Inc.Phase 2 Completed226 enrolled
NCT00054899 2010-03-24An Open Label Study of a Peptide Vaccine in Patients With Stage IIb or IIIa Non-Small Cell Lung CancerEpimmunePhase 1 Completed18 enrolled
NCT00102505 2009-04-03A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC)Pharmacyclics LLC.Phase 1 Completed36 enrolled